1. Home
  2. CELU vs CRWS Comparison

CELU vs CRWS Comparison

Compare CELU & CRWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • CRWS
  • Stock Information
  • Founded
  • CELU 2016
  • CRWS 1957
  • Country
  • CELU United States
  • CRWS United States
  • Employees
  • CELU N/A
  • CRWS N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • CRWS Textiles
  • Sector
  • CELU Health Care
  • CRWS Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • CRWS Nasdaq
  • Market Cap
  • CELU 42.2M
  • CRWS 39.8M
  • IPO Year
  • CELU N/A
  • CRWS N/A
  • Fundamental
  • Price
  • CELU $1.82
  • CRWS $3.64
  • Analyst Decision
  • CELU
  • CRWS
  • Analyst Count
  • CELU 0
  • CRWS 0
  • Target Price
  • CELU N/A
  • CRWS N/A
  • AVG Volume (30 Days)
  • CELU 162.2K
  • CRWS 17.6K
  • Earning Date
  • CELU 12-06-2024
  • CRWS 02-12-2025
  • Dividend Yield
  • CELU N/A
  • CRWS 8.74%
  • EPS Growth
  • CELU N/A
  • CRWS N/A
  • EPS
  • CELU N/A
  • CRWS 0.24
  • Revenue
  • CELU $48,200,000.00
  • CRWS $86,602,000.00
  • Revenue This Year
  • CELU N/A
  • CRWS N/A
  • Revenue Next Year
  • CELU $233.89
  • CRWS N/A
  • P/E Ratio
  • CELU N/A
  • CRWS $15.65
  • Revenue Growth
  • CELU 225.94
  • CRWS N/A
  • 52 Week Low
  • CELU $1.00
  • CRWS $3.64
  • 52 Week High
  • CELU $5.69
  • CRWS $5.39
  • Technical
  • Relative Strength Index (RSI)
  • CELU 48.24
  • CRWS 26.39
  • Support Level
  • CELU $1.64
  • CRWS $3.63
  • Resistance Level
  • CELU $2.40
  • CRWS $3.93
  • Average True Range (ATR)
  • CELU 0.20
  • CRWS 0.07
  • MACD
  • CELU 0.03
  • CRWS -0.01
  • Stochastic Oscillator
  • CELU 26.26
  • CRWS 9.09

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

Share on Social Networks: